Your browser doesn't support javascript.
[Drug therapy interventions for acute SARS-CoV-2 infection: who, when, and what?] / Medikamentöse Therapiemaßnahmen bei akuter SARS-CoV-2-Infektion: wer, wann und was?
Sensen, Barbara; Wichmann, Dominic; Kluge, Stefan.
  • Sensen B; Klinik für Intensivmedizin des Zentrums für Anästhesiologie und Intensivmedizin am Universitätsklinikum, Hamburg-Eppendorf, Hamburg.
  • Wichmann D; Klinik für Intensivmedizin des Zentrums für Anästhesiologie und Intensivmedizin am Universitätsklinikum, Hamburg-Eppendorf, Hamburg.
  • Kluge S; Klinik für Intensivmedizin des Zentrums für Anästhesiologie und Intensivmedizin am Universitätsklinikum, Hamburg-Eppendorf, Hamburg.
Pneumologie ; 77(1): 21-26, 2023 Jan.
Article in German | MEDLINE | ID: covidwho-2212111
ABSTRACT
There is a variety of drug therapy options for treatment of acute SARS-CoV-2 infections. The updated S3 guideline "Recommendations for inpatient therapy of patients with COVID-19" provides clear recommendations in this regard. Which therapy is best suited for which patient and in which phase of the disease must be decided individually based on risk factors, comorbidities and contraindications. This article provides an overview.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: German Journal: Pneumologie Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: German Journal: Pneumologie Year: 2023 Document Type: Article